Frontiers in cancer prevention research: Defeating cancer before it strikes
The American Association for Cancer Research hosting third annual international conference on frontiers in cancer prevention research
WHAT: To turn back cancer before it has a chance to take root and spread, scientists are increasingly turning their attention to new discoveries in cancer prevention. Leading experts from around the globe are gathering to share the latest research in this expanding and promising new field, with the hope this work will significantly reduce cancer incidence and mortality.
The future of cancer prevention relies heavily on:
identifying promising targets for drug development;
understanding how personal decisions are linked to cancer and identifying high-risk populations;
developing pre-clinical drug-testing models; and
tailoring prevention strategies to genetic profiles.
WHEN: Saturday – Wednesday, October 16 – 20, 2004
WHERE: Washington State Convention & Trade Center Seattle, WA
AACR Press Room: Location: Room 309, Third Level Hours: 8:00 am – 6:00 pm Daily Telephone: 206-219-4772 Fax: 206-219-4773 E-mail: communications@aacr.org Press Briefing Schedule: These briefings are only open to members of the media.
Sunday, October 17th
Diabetes, Infection and Dietary Risks: 9:30 am – 10:30 am PST (12:30 pm EST)
Risks Linked to Prostate and Stomach Cancer: 11:30 am – 12:30 pm PST (2:30 pm EST)
Monday, October 18th
Antioxidants, Food Extracts and Prevention: 9:30 am – 10:30 am PST (12:30 pm EST)
Early Warnings & Diagnosis of Gender-Related Cancers: 11:30 am – 12:30 pm PST (2:30 pm EST)
Tuesday, October 19th
New Tools in Chemoprevention against Prostate, Colon & Skin Cancers: 9:30 am – 10:30 am PST (12:30 pm EST) -
SPECIAL SESSION: Panel Discussion on Vioxx: 1:15 pm – 2:15 pm PST (4:15 pm EST)
The Vioxx panel discussion is not a press conference; this special session was recently added to the meeting's program. Moderated by Dr. John Potter, Chairperson of the Program Committee, leading researchers in the field will address the withdrawal of Vioxx from the market and the resulting implications on future preventative research and treatment programs.
Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 24,000 laboratory, translational, and clinical scientists engaged in cancer research in the United States and more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). AACR's Annual Meeting attracts more than 15,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational and clinical cancer research.
